VWA
JAZZ icon

Valued Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Valued Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.82K Buy
20
+2
+11% +$438 ﹤0.01% 455
2026
Q1 		$3.4K Buy
18
+15
+500% +$2.62K ﹤0.01% 459
2025
Q4 		$510 Buy
3
+1
+50% +$153 ﹤0.01% 533
2025
Q3 		$264 Hold
2
– – ﹤0.01% 560
2025
Q2 		$213 Hold
2
– – ﹤0.01% 572
2025
Q1 		$249 Hold
2
– – ﹤0.01% 597
2024
Q4 		$247 Hold
2
– – ﹤0.01% 602
2024
Q3 		$223 Hold
2
– – ﹤0.01% 591
2024
Q2 		$214 Sell
2
-16
-89% -$1.76K ﹤0.01% 558
2024
Q1 		$2.17K Buy
18
+15
+500% +$1.84K ﹤0.01% 348
2023
Q4 		$389 Buy
+3
New +$374 ﹤0.01% 456

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Valued Wealth Advisors's JAZZ Position: Q2 2026 in Review

Valued Wealth Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q2 2026, buying an estimated $438 and bringing the position to 20 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Valued Wealth Advisors first reported a position in JAZZ in Q4 2023 and has held it in 11 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Valued Wealth Advisors held 20 shares of Jazz Pharmaceuticals worth $4.82K as of Q2 2026.
  • Valued Wealth Advisors bought 2 Jazz Pharmaceuticals shares in Q2 2026, an estimated $438.
  • Jazz Pharmaceuticals made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #455 holding.
  • Valued Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.